InVitro Cell Research, LLC
Michael Boyer, PhD, is a Senior Scientist at InVitro Cell Research, LLC. Prior to this, Michael worked as a Postdoctoral Research Fellow at Yale University School of Medicine, focusing on the interaction between low density lipoproteins and the endothelial transcytosis partner Alk1. Michael also studied the role of extracellular vesicles in cellular crosstalk between the vascular endothelium and smooth muscle cells during their time as a Graduate Student at Temple University. With a background in Biology from Penn State University, Michael has a strong foundation in cardiovascular physiology and a proven track record in scientific research and product quality control.
InVitro Cell Research, LLC
InVitro Cell Research, LLC (ICR) is a privately funded company focused on regenerative and preventive personalized medicine. We are dedicated to discovering and developing interventions to slow and reverse biological aging and prevent major age-related diseases. ICR has a small-group vibe and a highly collaborative work environment. We invest in our scientists, providing them the state-of-the-art resources they need to leverage their time and skills most effectively, empowering small teams to accomplish the amazing and advance our mission. Our mission is to research ways to repair aging people, fast.